Nabil Elshafeey

Nabil Elshafeey, M.D., currently serves as the Medical Director of Neuro and Rare Disease at Telix Pharmaceuticals Limited, focusing on advancing precision medicine solutions for oncology and rare neurological disorders since November 2024. Previously, Nabil held the position of Medical Director of Radiology at Imaging Endpoints from September 2021 to November 2024, and prior to that, was a Senior Research Scientist, Senior Clinical Research Scientist, and Postdoctoral Fellow at MD Anderson Cancer Center from January 2015 to November 2021, where responsibilities included guiding the Imaging Analysis team and driving compliance initiatives. Early career experiences include serving as a Senior Radiology Resident at Maadi Hospital and completing an internship at El Kasr El Ainy, Cairo University Hospitals. Nabil obtained a Medical Degree from Cairo University and completed research training as a Post-Doctoral Fellow at the University of Texas M.D. Anderson Cancer Center.